Federal Register Notice: FDA will consider comments submitted through 5/29, for a draft guidance for industry entitled Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration. The comment period ended 4/30, but due to confusion as to the closing date for comments on the draft guidance, FDA is extending it. To view this notice, click here.
